Evidence map›Paper›PMID 30282821›Full record

ArticleJCI insight2018

Somatostatin receptor subtype 5 modifies hypothalamic-pituitary-adrenal axis stress function.

Masaaki Yamamoto, Anat Ben-Shlomo, Hiraku Kameda, Hidenori Fukuoka, Nan Deng, Yan Ding, Shlomo Melmed

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JCI insight, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04066647 (Detection of miRNAs in HPA Axis Function in Healthy Subjects), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04066647 phase1 / phase2terminatednot on this mapstarted 2019, after this paper: background citation

Detection of miRNAs in HPA Axis Function in Healthy Subjects

TypeinterventionalSponsorCedars-Sinai Medical CenterRan2019 to 2019Enrolled7ConditionsDexamethasone Effect on miRNA Profile in Healthy HumansArmsDexamethasone 4mg
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Masaaki YamamotoPituitary Center, Department of Medicine, and.
Anat Ben-ShlomoPituitary Center, Department of Medicine, and.
Hiraku KamedaPituitary Center, Department of Medicine, and.
Hidenori FukuokaPituitary Center, Department of Medicine, and.
Nan DengBiostatistics and Bioinformatics Research Center, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Yan DingPituitary Center, Department of Medicine, and.
Shlomo MelmedPituitary Center, Department of Medicine, and.
Cedars-Sinai Medical Center · US

Funding

Training Program in Endocrinology, Diabetes, and MetabolismT32DK007770 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI MELMED, SHLOMO · 1999 to 2022
$3.4M
Mechanisms for GH action on epithelial cellsR01DK113998 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI SHLOMO MELMED · 2018 to 2026
$3.0M
Treatment of pituitary Cushing disease with a selective CDK inhibitor, R-roscovitR21DK103198 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI MELMED, SHLOMO · 2014 to 2015
$445k
NIDDK NIH HHS R01 DK113998NIDDK NIH HHS R21 DK103198NIDDK NIH HHS T32 DK007770
6 · The paper itself

Abstract

Pituitary corticotroph somatostatin receptor subtype 5 (SSTR5) signals to inhibit adrenocorticotrophin (ACTH) secretion. As ACTH deficiency results in attenuated adrenal cortisol production and an impaired stress response, we sought to clarify the role of SSTR5 in modifying the hypothalamic/pituitary/adrenal (HPA) axis. We generated Tg HP5 mice overexpressing SSTR5 in pituitary corticotrophs that produce the ACTH precursor proopiomelanocortin (POMC). Basal ACTH and corticosterone were similar in HP5 and WT mice, while HP5 mice showed attenuated ACTH and corticosterone responses to corticotrophin releasing hormone (CRH). HP5 mice exhibited attenuated corticosterone responses upon a restraint stress test and inflammatory stress following LPS injection, as well as increased anxiety-like and depressive-like behavior on open field and forced swim tests. Pituitary corticotroph CRH receptor subtype 1 (CRHR1) mRNA expression and ACTH responses to CRH were also attenuated in HP5 mice. In AtT20 cells stably overexpressing SSTR5, CRHR1 expression and cAMP response to CRH were reduced, whereas both were increased after SSTR5 KO. In elucidating mechanisms for these observations, we show that SSTR5-induced miR-449c suppresses both CRHR1 expression and function. We conclude that corticotroph SSTR5 attenuates HPA axis responses via CRHR1 downregulation, suggesting a role for SSTR5 in the pathogenesis of secondary adrenal insufficiency.

Indexed as

Adrenal InsufficiencyAdrenocorticotropic HormoneAnimalsCell Line, TumorCorticosteroneCorticotrophsCRF Receptor, Type 1Disease Models, AnimalDown-RegulationFemaleHumansHypothalamo-Hypophyseal SystemMaleMiceMice, TransgenicMicroRNAsAdrenocorticotropic HormoneCorticosteroneCRF Receptor, Type 1MicroRNAsMirn449 microRNA, mouseReceptors, Corticotropin-Releasing HormoneReceptors, Somatostatinsomatostatin receptor 5Endocrinologygrowth factorsNeuroendocrine regulation

Identifiers

PMID30282821
PMCPMC6237446
OpenAlexW2895465785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.